COVID-19 vaccine export may start in 2 weeks, says Serum Institute CEO Adar Poonawalla

COVID-19 vaccine export may start in 2 weeks, says Serum Institute CEO Adar Poonawalla

By Administrator_India

Capital Sands

Export of COVID-19 vaccines can start in about next two weeks, the Business Standard reported, quoting Serum Institute of India (SII)’s Chief Executive Officer (CEO) Adar Poonawalla.

The news report further cites Poonawalla as saying that exports of the vaccine doses will start only after local requirements are fully met.

Further, the Serum Institute will start producing the Novavax vaccine candidate at its facility in “around two months from now.” Poonawalla told the newspaper that his company was making preparations and working on regulatory protocols.

The Novavax COVID-19 vaccine candidate is currently under clinical trial in the United States and would have to go through a bridging trial in India.

SII is already manufacturing doses of ‘Covishield’, the COVID-19 vaccine developed by Oxford University and pharmaceutical giant AstraZeneca. The vaccine was granted emergency use authorisation in India earlier this month.

Covishield is one of the two jabs being used as part of the “world’s largest” vaccination exercise that was flagged off by Prime Minister Narendra Modi on January 16.

 

Priority is being given to healthcare and frontline workers, who had already been registered on the purpose-built CoWIN application. This would be sequentially followed by people with comorbidities, senior citizens, and finally, the general public. The Centre is hoping to vaccinate 30 crore people by July, in a bid to stop the novel coronavirus pandemic.

As of January 17, India had reported more than 1.05 crore confirmed COVID-19 cases. The death toll from the outbreak in the country stood at over 1.52 lakh. While more than 1.01 crore patients had recovered, 2.11 lakh cases remained ‘active’. Globally, more than 9.44 crore individuals have been infected by the virus and over 20.24 lakh people have died so far.

A speedy rollout of vaccines is being seen as the best way to curb the spread of COVID-19 and restore normalcy in the pandemic-battered global economy. More than 50 countries, including the United States and the United Kingdom, have already vaccinated a large number of people from high-risk groups.

Related Posts
India reports 4,194 new COVID-19 cases, 255 deaths from virus in 24 hours
new Covid cases

India reported 4,194 new COVID-19 cases in the last 24 hours taking the total confirmed tally to 4,29,84,261 while active infections continued Read more

ब्रिटेन में 12 साल से कम उम्र के बच्चों को भी लगेगी Covid वैक्सीन, रेगुलेटरी एजेंसी ने दी मंजूरी
कोरोना वायरस (Coronavirus) के नए और अधिक संक्रामक वेरिएंट ओमिक्रॉन (Omicron) के सामने आने के बाद ब्रिटेन में हालात बिगड़ते जा रहे हैं.

कोरोना वायरस (Coronavirus) के नए और अधिक संक्रामक वेरिएंट ओमिक्रॉन (Omicron) के सामने आने के बाद ब्रिटेन में हालात बिगड़ते Read more

Serum, Bharat Biotech vaccines get restricted use approval from DCGI
COVID-19 vaccine export may start in 2 weeks, says Serum Institute CEO Adar Poonawalla

By Administrator_India Capital Sands India’s drug regulator on Sunday gave its final approval to the Oxford-AstraZeneca and Bharat Biotech coronavirus vaccines for restricted use Read more

Britain must vaccinate two million a week to prevent a third COVID-19 wave: Study
COVID-19 vaccine export may start in 2 weeks, says Serum Institute CEO Adar Poonawalla

By Administrator_India Capital Sands Britain must vaccinate two million people a week to avoid a third wave of the coronavirus Read more

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x